Antibacterial Haemostatic Gels Market - Top Companies and Manufacturers

  • Report ID: 5907
  • Published Date: Nov 27, 2024
  • Report Format: PDF, PPT

Companies Dominating the Antibacterial Haemostatic Gels Market

    • Pfizer Inc.
      • Company Overview
      • Business Planning
      • Main Product Offerings
      • Financial Execution
      • Main Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • DEXX Laboratories Inc.
    • Medura
    • StopBleed
    • Zoetis Inc
    • Rapid-Seal
    • Coloplast Group
    • Gel-e-life sciences
    • PREVESTDenPro
    • Bio-Chem LLC
    • Smith & Nephew
    • Medtronic
    • B. Braun SE
    • 3M Company

Browse Key Market Insights with Data Illustration:

In the News

 Pfizer Inc. declared that the European Commission (EC) has accepted marketing permission for the organization’s 20-valent pneumococcal conjugate vaccine, sold in the European Union under the brand name PREVENAR 20®, for active vaccination for the hindrance of invasive disease, pneumonia and keen otitis media affected by Streptococcus pneumoniae in toddlers, kids, and adolescents from 6 weeks to lower than 18 years of age.

 Pfizer Inc. the transplant organization, declared a leading existence and the fifth successive year as the Distinguished Founder’s Circle Sponsor for the Annual American Society of Transplant Surgeons (ASTS) Winter Symposium organized on January 11 - 14, 2024 in Miami, Florida.


Author Credits:  Radhika Pawar


  • Report ID: 5907
  • Published Date: Nov 27, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of antibacterial haemostatic gels is evaluated at USD 1.57 billion.

The antibacterial haemostatic gels market size was valued at USD 1.49 billion in 2024 and is set to exceed USD 3.3 billion by 2037, expanding at over 6.3% CAGR during the forecast period i.e., between 2025-2037. The increase in surgical techniques across the world will drive the market growth.

North America industry is predicted to dominate majority revenue share of 43% by 2037, owing to rising advancement of healthcare infrastructure in this region.

The major players in the market are Pfizer Inc., DEXX Laboratories Inc., Medura, StopBleed, Zoetis Inc., Rapid-Seal, Coloplast Group, Gel-e-life sciences, PREVESTDenPro, Bio-Chem LLC, Smith & Nephew, Medtronic, B. Braun SE, 3M.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample